Amila Silva, MD
Ophthalmology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 31
- 8 carriers
- Offices
- 5
Offices
5 locations · Stanford Health Care · Vitreo-Retinal Medical Group, Inc. · Erie Retinal Surgery, Inc.
Looking this up.
Plans that list them
31 plans · 8 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Silva’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
31 of 31 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A121303 · Current
Licensed to practise in California · since 2012 · expires 2027-10-31 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Florida ME149236Medical Doctor · since 2021 · expires 2027-01-31ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
School, training and certification
3 placements
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Education
- Stanford School of Medicine2003–2008
Residency and fellowship
- Stanford University - Byers Eye Institute at Stanford, OPHTHALMOLOGYPalo Alto, US · 2012–2014
- Bascom Palmer Eye Institute, OPHTHALMOLOGYMiami, US · 2009–2012
- University of California Irvine, INTERNAL MEDICINEOrange, US · 2008–2009
What else the board holds
Hospitals they may admit to
Where the clinician told their state board they may admit and treat patients.
- Out of State
Also licensed in
States the clinician told their board they are also licensed in. Only the states we check are verified.
California · Washington
Original Medicare doctor bills
$1,757,847
Medicare paid this office $1,757,847 for 940 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Injection, faricimab-svoa, 0.1 mg | 118 | $683,258 | None |
| Injection, pegcetacoplan, intravitreal, 1 mg | 27 | $198,848 | None |
| Injection, aflibercept, 1 mg | 52 | $193,454 | None |
| Established patient complete exam of visual system | 724 | $151,944 | $103 |
| Injection of drug into eye | 288 | $98,003 | $97 |
See all 27 services
| Injection, faricimab-svoa, 0.1 mg | 118 | $683,258 | None |
| Injection, pegcetacoplan, intravitreal, 1 mg | 27 | $198,848 | None |
| Injection, aflibercept, 1 mg | 52 | $193,454 | None |
| Established patient complete exam of visual system | 724 | $151,944 | $103 |
| Injection of drug into eye | 288 | $98,003 | $97 |
| Chloroprocaine hcl ophthalmic, 3% gel, 1 mg | 89 | $83,610 | None |
| Imaging of retina | 840 | $58,572 | $34 |
| Established patient problem focused exam of visual system | 231 | $28,686 | $76 |
| Injection, ranibizumab, 0.1 mg | 21 | $28,472 | None |
| Removal of membrane of retina with removal of internal limiting membrane of retina | 16 | $17,120 | $1,007 |
| New patient complete exam of visual system | 136 | $16,388 | $120 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 107 | $15,915 | $140 |
| Repair of detached retina with drainage and removal of eye fluid between lens and retina | 12 | $11,538 | $962 |
| Compounded drug, not otherwise classified | 75 | $9,997 | None |
| Extended exam of the back part of the eye with optic nerve drawing | 472 | $9,248 | $13 |
| Extended exam of the back part of the eye with retinal drawing | 284 | $7,439 | $20 |
| Injection, bevacizumab, 10 mg | 33 | $5,663 | None |
| Imaging of front third of eye using a special camera after injection of a dye | 40 | $5,435 | $126 |
| Repair of detached retina using a laser | 13 | $5,354 | $255 |
| New patient visit (45+ min) | 28 | $3,854 | $138 |
| Return visit (30+ min) | 30 | $3,584 | $97 |
| Photocoagulation treatment to prevent detachment of retina | 11 | $2,703 | $208 |
| 2d ultrasound scan of eye tissue and structures | 49 | $2,375 | $37 |
| Photography of the retina | 58 | $1,787 | $30 |
| Injection of drug or substance into membrane covering eyeball | 15 | $578 | $34 |
| Hemoglobin a1c level | 18 | $200 | $10 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 12 | $41 | None |
Procedures Medicare counted
| Cataract surgery | 1-10 | None |
Who their Medicare patients are
940 Original Medicare patients in 2024. Average age 77 · Under 65 4% · 85 and older 22% · Women 57% · Also on Medicaid 13% · Health risk score 1.41. Above the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 75% · Diabetes 42% · Coronary heart disease 35% · Chronic kidney disease 25% · Atrial fibrillation 20% · Heart failure 19% · Cancer 17% · Depression 15% · COPD 14% · Stroke 10% · Dementia 7%.
The office billed $4,322,896, Medicare allowed $2,237,534 and paid $1,757,847; for 198,484 services of 65 kinds; $1,268,960 of it was for drugs given in the office and $488,887 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 940 | 198,484 | 77 | 1.41 | $4,322,896 | $1,757,847 |
| 2023 | 1,009 | 12,162 | 76 | 1.48 | $2,358,231 | $783,043 |
| 2022 | 1,132 | 5,428 | 75 | 1.46 | $2,279,386 | $840,914 |
| 2021 | 906 | 4,707 | 75 | 1.51 | $1,973,883 | $688,636 |
| 2020 | 949 | 4,409 | 74 | 1.62 | $1,420,787 | $293,493 |
| 2019 | 1,031 | 4,710 | 74 | 1.53 | $1,699,165 | $326,684 |
| 2018 | 1,023 | 5,073 | 73 | 1.42 | $2,151,011 | $404,476 |
| 2017 | 1,093 | 5,412 | 73 | 1.55 | $2,524,497 | $432,887 |
| 2016 | 923 | 4,093 | 73 | 1.58 | $2,070,529 | $327,113 |
| 2015 | 544 | 3,279 | 75 | 1.50 | $1,900,792 | $433,325 |
| 2014 | 354 | 1,072 | 73 | 1.36 | $632,423 | $136,056 |
| 2013 | 205 | 310 | 73 | 1.48 | $384,125 | $26,005 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 22 services
| Injection, faricimab-svoa, 0.1 mg | 74 | $200,394 | None |
| Injection, aflibercept, 1 mg | 63 | $119,822 | None |
| Injection, pegcetacoplan, intravitreal, 1 mg | 22 | $68,606 | None |
| Injection of drug into eye | 304 | $59,226 | $98 |
| Established patient complete exam of visual system | 391 | $55,635 | $112 |
| Return visit (30+ min) | 387 | $51,740 | $85 |
| Injection, ranibizumab, 0.1 mg | 34 | $42,699 | None |
| Imaging of retina | 937 | $38,277 | $28 |
| Unclassified drugs | 14 | $30,064 | None |
| New patient visit (45+ min) | 160 | $17,841 | $112 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 67 | $7,325 | $108 |
| Established patient problem focused exam of visual system | 69 | $6,282 | $79 |
| Destruction of leaking blood vessels of retina using laser | 12 | $4,609 | $288 |
| New patient complete exam of visual system | 29 | $3,715 | $128 |
| Compounded drug, not otherwise classified | 40 | $3,583 | None |
| Imaging of front third of eye using a special camera after injection of a dye | 22 | $3,024 | $137 |
| Extended exam of the back part of the eye with retinal drawing | 113 | $2,654 | $22 |
| Extended exam of the back part of the eye with optic nerve drawing | 171 | $2,629 | $14 |
| New patient visit (60+ min) | 18 | $2,576 | $143 |
| 2d ultrasound scan of eye tissue and structures | 46 | $1,734 | $33 |
| Photography of the retina | 18 | $582 | $31 |
| Hemoglobin a1c level | 18 | $181 | $10 |
2022: 20 services
| Injection, aflibercept, 1 mg | 132 | $458,758 | None |
| Injection, ranibizumab, 0.1 mg | 32 | $83,456 | None |
| Injection of drug into eye | 243 | $53,485 | $94 |
| Return visit (30+ min) | 420 | $49,050 | $88 |
| New patient visit (45+ min) | 407 | $46,298 | $114 |
| Imaging of retina | 1,011 | $40,328 | $27 |
| Established patient complete exam of visual system | 222 | $21,757 | $93 |
| Removal of membrane of retina with removal of internal limiting membrane of retina | 17 | $16,234 | $955 |
| Photography of the retina | 353 | $10,416 | $26 |
| Established patient problem focused exam of visual system | 76 | $5,921 | $68 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 67 | $5,635 | $84 |
| Short return visit (20+ min) | 64 | $4,813 | $63 |
| New patient visit (60+ min) | 20 | $3,210 | $161 |
| Compounded drug, not otherwise classified | 27 | $2,552 | None |
| 2d ultrasound scan of eye tissue and structures | 60 | $1,982 | $29 |
| Long return visit (40+ min) | 11 | $1,704 | $131 |
| Short return visit | 15 | $706 | $44 |
| Extended exam of the back part of the eye with optic nerve drawing | 54 | $597 | $10 |
| Extended exam of the back part of the eye with retinal drawing | 15 | $340 | $21 |
| Imaging of optic nerve | 12 | $246 | $20 |
2021: 20 services
| Injection, aflibercept, 1 mg | 83 | $348,598 | None |
| Injection of drug into eye | 253 | $50,899 | $84 |
| Return visit (30+ min) | 397 | $47,626 | $77 |
| Injection, ranibizumab, 0.1 mg | 20 | $46,853 | None |
| New patient visit (45+ min) | 284 | $36,376 | $128 |
| Imaging of retina | 787 | $33,261 | $25 |
| Established patient complete exam of visual system | 176 | $16,080 | $87 |
| Complex repair of detached retina and drainage of eye fluid between lens and retina | 12 | $15,096 | $1,078 |
| Removal of membrane of retina with removal of internal limiting membrane of retina | 14 | $13,484 | $963 |
| Photography of the retina | 351 | $12,597 | $30 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 100 | $8,555 | $85 |
| Destruction of leaking blood vessels of retina using laser | 13 | $4,810 | $267 |
| Short return visit (20+ min) | 50 | $4,563 | $74 |
| Long return visit (40+ min) | 34 | $4,135 | $122 |
| New patient visit (60+ min) | 19 | $3,080 | $162 |
| Established patient problem focused exam of visual system | 35 | $2,973 | $71 |
| 2d ultrasound scan of eye tissue and structures | 46 | $1,937 | $32 |
| Compounded drug, not otherwise classified | 17 | $1,496 | None |
| Short return visit | 18 | $857 | $45 |
| Extended exam of the back part of the eye with optic nerve drawing | 54 | $741 | $13 |
2020: 15 services
| Return visit (30+ min) | 693 | $90,598 | $67 |
| Injection of drug into eye | 161 | $60,150 | $93 |
| Imaging of retina | 901 | $36,843 | $22 |
| New patient visit (45+ min) | 178 | $17,807 | $100 |
| Removal of membrane of retina with removal of internal limiting membrane of retina | 12 | $12,242 | $1,020 |
| Long return visit (40+ min) | 116 | $10,958 | $93 |
| Destruction of leaking blood vessels of retina using laser | 14 | $9,250 | $289 |
| New patient visit (60+ min) | 40 | $5,553 | $139 |
| 2d ultrasound scan of eye tissue and structures | 50 | $2,101 | $27 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 36 | $1,392 | $39 |
| Exam of visual field with extended testing | 21 | $588 | $27 |
| Measurement of corneal curvature and depth of eye | 18 | $537 | $30 |
| Extended exam of the back part of the eye with retinal drawing | 26 | $516 | $19 |
| Imaging of optic nerve | 13 | $303 | $22 |
| Ct scan of cornea | 12 | $210 | $18 |
2019: 16 services
| Return visit (30+ min) | 539 | $66,650 | $71 |
| Injection of drug into eye | 140 | $54,338 | $91 |
| Imaging of retina | 983 | $42,350 | $23 |
| Established patient complete exam of visual system | 352 | $24,687 | $58 |
| New patient visit (45+ min) | 205 | $20,341 | $99 |
| Long return visit (40+ min) | 181 | $17,980 | $96 |
| Complex repair of detached retina and drainage of eye fluid between lens and retina | 13 | $17,705 | $1,265 |
| Removal of membrane of retina with removal of internal limiting membrane of retina | 12 | $13,258 | $1,105 |
| Removal of eye fluid (vitreous) between lens and retina | 12 | $8,375 | $644 |
| New patient visit (60+ min) | 45 | $6,650 | $148 |
| Removal of recurring cataract in lens capsule using a laser | 13 | $4,159 | $297 |
| 2d ultrasound scan of eye tissue and structures | 75 | $3,274 | $31 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 43 | $1,664 | $38 |
| Examination of eye by ophthalmoscope with retinal drawing | 52 | $1,003 | $18 |
| Measurement of corneal curvature and depth of eye | 17 | $512 | $30 |
| Exam of visual field with extended testing | 17 | $451 | $27 |
2018: 22 services
| Established patient complete exam of visual system | 671 | $84,308 | $68 |
| Injection of drug into eye | 171 | $58,122 | $87 |
| Injection, aflibercept, 1 mg | 12 | $53,225 | None |
| Imaging of retina | 963 | $44,776 | $24 |
| Removal of membrane of retina with removal of internal limiting membrane of retina | 18 | $19,626 | $1,090 |
| Complex repair of detached retina and drainage of eye fluid between lens and retina | 12 | $19,488 | $1,218 |
| New patient visit (45+ min) | 177 | $17,123 | $97 |
| Long return visit (40+ min) | 147 | $14,678 | $95 |
| Destruction of leaking blood vessels of retina using laser | 14 | $8,842 | $285 |
| Complex removal of cataract with insertion of prosthetic lens | 11 | $8,209 | $684 |
| Photocoagulation treatment to prevent detachment of retina | 13 | $7,151 | $447 |
| Established patient problem focused exam of visual system | 74 | $7,055 | $58 |
| Compounded drug, not otherwise classified | 39 | $5,814 | None |
| New patient visit (60+ min) | 41 | $5,520 | $135 |
| Return visit (30+ min) | 73 | $5,301 | $68 |
| 2d ultrasound scan of eye tissue and structures | 49 | $3,227 | $40 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 49 | $2,015 | $41 |
| New patient complete exam of visual system | 12 | $938 | $78 |
| Examination of eye by ophthalmoscope with retinal drawing | 44 | $785 | $15 |
| Photography of the retina | 13 | $412 | $32 |
| Measurement of corneal curvature and depth of eye | 13 | $355 | $27 |
| Exam of visual field with extended testing | 11 | $289 | $26 |
2017: 19 services
| Established patient complete exam of visual system | 757 | $92,593 | $74 |
| Injection of drug into eye | 178 | $59,656 | $89 |
| Imaging of retina | 989 | $48,169 | $25 |
| Removal of membrane of retina with removal of internal limiting membrane of retina | 18 | $21,302 | $1,065 |
| Complex repair of detached retina and drainage of eye fluid between lens and retina | 13 | $19,882 | $1,243 |
| New patient visit (45+ min) | 182 | $17,829 | $98 |
| Established patient problem focused exam of visual system | 121 | $15,585 | $63 |
| Long return visit (40+ min) | 148 | $14,274 | $95 |
| Destruction of leaking blood vessels of retina using laser | 21 | $11,412 | $278 |
| Compounded drug, not otherwise classified | 52 | $10,166 | None |
| New patient visit (60+ min) | 47 | $6,319 | $134 |
| Photocoagulation treatment to prevent detachment of retina | 11 | $5,791 | $445 |
| 2d ultrasound scan of eye tissue and structures | 55 | $4,512 | $52 |
| New patient complete exam of visual system | 20 | $1,941 | $97 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 43 | $1,764 | $41 |
| Examination of eye by ophthalmoscope with retinal drawing | 68 | $1,599 | $19 |
| Return visit (30+ min) | 22 | $1,391 | $63 |
| Short return visit (20+ min) | 29 | $1,299 | $43 |
| Photography of the retina | 27 | $1,258 | $42 |
2016: 20 services
| Established patient complete exam of visual system | 500 | $61,972 | $80 |
| Injection of drug into eye | 141 | $41,192 | $90 |
| Imaging of retina | 730 | $39,063 | $28 |
| New patient visit (45+ min) | 217 | $21,331 | $98 |
| Complex repair of detached retina and drainage of eye fluid between lens and retina | 12 | $15,534 | $1,294 |
| Removal of membrane of retina with removal of internal limiting membrane of retina | 12 | $14,111 | $1,085 |
| Return visit (30+ min) | 170 | $12,115 | $56 |
| Destruction of leaking blood vessels of retina using laser | 20 | $11,369 | $316 |
| Long return visit (40+ min) | 115 | $10,906 | $93 |
| New patient visit (60+ min) | 62 | $8,947 | $144 |
| Established patient problem focused exam of visual system | 68 | $7,724 | $70 |
| 2d ultrasound scan of eye tissue and structures | 63 | $6,798 | $52 |
| Compounded drug, not otherwise classified | 34 | $5,834 | None |
| Photocoagulation treatment to prevent detachment of retina | 12 | $5,614 | $432 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 43 | $3,985 | $50 |
| Short return visit (20+ min) | 41 | $2,579 | $45 |
| Examination of eye by ophthalmoscope with retinal drawing | 65 | $1,735 | $19 |
| New patient complete exam of visual system | 12 | $1,410 | $118 |
| Photography of the retina | 17 | $765 | $45 |
| Exam of visual field with extended testing | 11 | $368 | $31 |
2015: 20 services
| Injection, aflibercept, 1 mg | 36 | $148,931 | None |
| Return visit (30+ min) | 292 | $34,209 | $65 |
| Injection of drug into eye | 73 | $28,410 | $105 |
| Return visit (30+ min) | 113 | $21,155 | $97 |
| Destruction of leaking blood vessels of retina using laser | 17 | $20,312 | $883 |
| Injection of drug into eye | 61 | $18,351 | $87 |
| Imaging of retina | 365 | $17,918 | $26 |
| Removal of membrane of retina with removal of internal limiting membrane of retina | 14 | $14,877 | $1,063 |
| New patient visit (45+ min) | 120 | $12,372 | $103 |
| Imaging of retina | 113 | $10,630 | $44 |
| Unclassified biologics | 39 | $6,595 | None |
| 2d ultrasound scan of eye tissue and structures | 28 | $4,529 | $50 |
| Short return visit (20+ min) | 38 | $4,314 | $71 |
| New patient visit (60+ min) | 25 | $3,736 | $149 |
| Long return visit (40+ min) | 26 | $3,681 | $99 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 39 | $3,493 | $42 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 21 | $2,876 | $103 |
| Short return visit (20+ min) | 19 | $1,231 | $46 |
| Established patient complete exam of visual system | 15 | $957 | $64 |
| Examination of eye by ophthalmoscope with retinal drawing | 32 | $830 | $19 |
2014: 14 services
| Injection of drug into eye | 44 | $9,573 | $94 |
| Return visit (30+ min) | 78 | $6,774 | $68 |
| Injection of drug into eye | 30 | $6,340 | $98 |
| New patient visit (45+ min) | 56 | $6,061 | $108 |
| Imaging of retina | 155 | $5,385 | $26 |
| Return visit (30+ min) | 39 | $4,804 | $100 |
| New patient visit (60+ min) | 16 | $2,393 | $150 |
| Imaging of retina | 43 | $2,346 | $43 |
| Established patient complete exam of visual system | 30 | $2,228 | $74 |
| Short return visit (20+ min) | 56 | $2,173 | $37 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 27 | $1,862 | $43 |
| Unclassified biologics | 16 | $1,519 | None |
| New patient visit (30+ min) | 17 | $1,148 | $68 |
| New patient complete exam of visual system | 11 | $1,014 | $92 |
2013: 7 services
| Removal of membrane of retina with removal of internal limiting membrane of retina | 20 | $4,302 | $215 |
| Return visit (30+ min) | 36 | $2,781 | $62 |
| Short return visit (20+ min) | 56 | $2,516 | $39 |
| Injection of drug into eye | 16 | $1,739 | $92 |
| Imaging of retina | 66 | $1,672 | $25 |
| New patient visit (45+ min) | 17 | $1,565 | $92 |
| Removal of eye fluid (vitreous) between lens and retina | 11 | $1,555 | $141 |
Medicaid work
$43,098 in 2024
Medicaid paid $43,098 for 1,268 billed services this clinician did in 2024, up to 49 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 331 | $18,934 |
| Intravitreal injection of a pharmacologic agent (separate procedure) | 202 | $9,508 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 438 | $9,319 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 47 | $1,899 |
| Bilateral extended ophthalmoscopy with drawing of optic nerve, with interpretation and report | 170 | $1,429 |
| Ophthalmoscopy, extended; with retinal drawing and scleral depression of peripheral retinal disease (eg, for retinal tear, retinal detachment, retinal tumor) with interpretation and report, unilateral or bilateral | 68 | $1,118 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 12 | $891 |
| 2024 | 1,268 | 7 | 49 | $43,098 |
| 2023 | 1,460 | 8 | 82 | $87,339 |
| 2022 | 1,085 | 7 | 75 | $46,901 |
| 2021 | 814 | 4 | 73 | $50,522 |
| 2020 | 2,479 | 8 | 98 | $122,055 |
| 2019 | 2,408 | 7 | 95 | $145,912 |
| 2018 | 1,999 | 7 | 100 | $110,231 |
See the largest Medicaid services in earlier years
2023
| Intravitreal injection of a pharmacologic agent (separate procedure) | 328 | $59,114 |
| Return visit (30+ min) | 360 | $11,035 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 597 | $10,420 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 76 | $2,840 |
| OFFICE/OP CONSLTJ NEW/EST PT HIGH MDM 55 MINUTES | 12 | $1,824 |
| Service | 47 | $1,628 |
| Ophthalmoscopy, extended; with retinal drawing and scleral depression of peripheral retinal disease (eg, for retinal tear, retinal detachment, retinal tumor) with interpretation and report, unilateral or bilateral | 17 | $336 |
| Bilateral extended ophthalmoscopy with drawing of optic nerve, with interpretation and report | 23 | $143 |
2022
| Intravitreal injection of a pharmacologic agent (separate procedure) | 142 | $23,437 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 544 | $10,439 |
| Return visit (30+ min) | 275 | $7,545 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 25 | $2,714 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 14 | $1,347 |
| FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT | 56 | $976 |
| New patient visit (45+ min) | 29 | $443 |
2021
| Intravitreal injection of a pharmacologic agent (separate procedure) | 169 | $36,636 |
| Return visit (30+ min) | 243 | $7,614 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 369 | $5,532 |
| FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT | 33 | $740 |
2020
| Intravitreal injection of a pharmacologic agent (separate procedure) | 662 | $71,467 |
| Return visit (30+ min) | 667 | $17,540 |
| Aflibercept injection | 14 | $17,098 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 997 | $11,900 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 24 | $2,476 |
| Service | 32 | $1,139 |
| Hospital outpatient clinic visit for assessment and management of a patient | 71 | $436 |
| Advance Care Planning discussed and documented advance care plan or surrogate decision maker documented in the medical record (DEM) (GER, Pall Cr) | 12 | $0 |
2019
| Intravitreal injection of a pharmacologic agent (separate procedure) | 631 | $105,103 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 952 | $15,726 |
| Return visit (30+ min) | 442 | $11,194 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 78 | $6,686 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 209 | $4,480 |
| Service | 80 | $2,384 |
| Long return visit (40+ min) | 16 | $340 |
2018
| Intravitreal injection of a pharmacologic agent (separate procedure) | 437 | $64,233 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 873 | $17,468 |
| Aflibercept injection | 13 | $12,413 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 530 | $9,572 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 44 | $3,953 |
| Service | 86 | $1,944 |
| Long return visit (40+ min) | 16 | $647 |
Drugs they prescribed that Part D paid
$31,273
Pharmacies billed $31,273 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
371 generic and 281 brand-name prescriptions · $31,273 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Prednisolone Acetate | 187 | $9,593 | $51 |
| Brimonidine | 31 | $2,663 | $86 |
| Ketorolac Tromethamine | 50 | $1,918 | $38 |
| Fluorometholone | 15 | $844 | $56 |
| Acetazolamide | 13 | $764 | $59 |
See all 11 drugs
| Prednisolone Acetate | 187 | $9,593 | $51 |
| Brimonidine | 31 | $2,663 | $86 |
| Ketorolac Tromethamine | 50 | $1,918 | $38 |
| Fluorometholone | 15 | $844 | $56 |
| Acetazolamide | 13 | $764 | $59 |
| Dorzolamide-Timolol | 56 | $712 | $13 |
| Moxifloxacin | 33 | $623 | $19 |
| Latanoprost | 65 | $622 | $10 |
| Polymyxin B Sul-Trimethoprim | 82 | $541 | $7 |
| Neomycin-Polymyxin-Dexameth | 21 | $243 | $12 |
| Timolol Maleate | 15 | $168 | $11 |
Year by year
| 2024 | 652 | 230 | None | 43% | $31,273 |
| 2023 | 209 | 103 | 0% (0) | 51% | $10,693 |
| 2022 | 351 | 143 | 0% (0) | 41% | $77,693 |
| 2021 | 295 | 151 | 0% (0) | 36% | $30,227 |
| 2020 | 143 | 64 | 0% (0) | 47% | $9,701 |
| 2019 | 216 | 69 | None | 45% | $14,823 |
| 2018 | 194 | 67 | 0% (0) | 55% | $12,771 |
| 2017 | 125 | 61 | None | 47% | $9,193 |
| 2016 | 117 | 45 | 0% (0) | 57% | $11,226 |
| 2015 | 104 | 38 | None | 32% | $5,361 |
| 2014 | 64 | 32 | None | 28% | $2,267 |
| 2013 | 111 | 51 | 0% (0) | None | $4,131 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Prednisolone Acetate | 64 | $3,410 | $53 |
| Ketorolac Tromethamine | 29 | $1,259 | $43 |
| Polymyxin B Sul-Trimethoprim | 28 | $245 | $9 |
| Latanoprost | 13 | $184 | $14 |
2022: 8 drugs
| Eylea | 26 | $57,406 | $2,208 |
| Prednisolone Acetate | 41 | $2,891 | $71 |
| Neomycin-Polymyxin-Dexameth | 83 | $1,204 | $15 |
| Ketorolac Tromethamine | 26 | $1,012 | $39 |
| Dorzolamide-Timolol | 34 | $881 | $26 |
| Fluorometholone | 12 | $845 | $70 |
| Brimonidine | 23 | $799 | $35 |
| Latanoprost | 26 | $335 | $13 |
2021: 8 drugs
| Fluorometholone | 24 | $1,946 | $81 |
| Prednisolone Acetate | 28 | $1,599 | $57 |
| Ketorolac Tromethamine | 39 | $1,268 | $33 |
| Neomycin-Polymyxin-Dexameth | 65 | $945 | $15 |
| Dorzolamide-Timolol | 16 | $604 | $38 |
| Brimonidine | 11 | $523 | $48 |
| Latanoprost | 24 | $365 | $15 |
| Timolol Maleate | 13 | $205 | $16 |
2020: 3 drugs
| Ketorolac Tromethamine | 44 | $1,332 | $30 |
| Prednisolone Acetate | 20 | $1,252 | $63 |
| Latanoprost | 15 | $239 | $16 |
2019: 5 drugs
| Prednisolone Acetate | 32 | $2,247 | $70 |
| Simbrinza | 11 | $1,756 | $160 |
| Ketorolac Tromethamine | 31 | $1,222 | $39 |
| Latanoprost | 31 | $459 | $15 |
| Timolol Maleate | 31 | $251 | $8 |
2018: 5 drugs
| Prednisolone Acetate | 52 | $3,168 | $61 |
| Ketorolac Tromethamine | 36 | $1,066 | $30 |
| Latanoprost | 21 | $372 | $18 |
| Timolol Maleate | 14 | $105 | $7 |
| Polymyxin B Sul-Trimethoprim | 12 | $88 | $7 |
2017: 4 drugs
| Prednisolone Acetate | 21 | $1,308 | $62 |
| Fluorometholone | 12 | $972 | $81 |
| Ketorolac Tromethamine | 15 | $673 | $45 |
| Latanoprost | 12 | $110 | $9 |
2016: 2 drugs
| Brimonidine | 21 | $1,922 | $92 |
| Prednisolone Acetate | 11 | $578 | $53 |
2015: 1 drug
| Dorzolamide | 11 | $305 | $28 |
2014: 1 drug
| Prednisolone Acetate | 11 | $712 | $65 |
2013: 4 drugs
| Brimonidine | 15 | $886 | $59 |
| Latanoprost | 15 | $212 | $14 |
| Timolol Maleate | 17 | $183 | $11 |
| Prednisolone Acetate | 11 | $133 | $12 |
Money from drug and device companies
$862 in 2024
| 2024 | 6 | 10 | $700 | $862 |
| 2023 | 2 | 4 | $2,100 | $2,130 |
| 2022 | 4 | 13 | $6,650 | $6,948 |
| 2021 | 8 | 32 | $11,900 | $13,500 |
| 2019 | 2 | 3 | None | $245 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Alcon Research | None | $700 | 1 payment
|
| Abbvie | Ozurdex | $66 | 3 payments
|
| Alimera Sciences | Yutiq | $52 | 3 payments
|
| Ocular Therapeutix | Dextenza | $16 | 1 payment
|
| Regeneron Healthcare Solutions | Eylea Hd | $14 | 1 payment
|
| Astellas Pharma US | Izervay | $14 | 1 payment
|
See all 10 published payments
| Ocular Therapeutix | Meals · 2024-12-11 | Dextenza | $16 |
| Abbvie | Meals · 2024-11-22 | Ozurdex | $34 |
| Regeneron Healthcare Solutions | Meals · 2024-11-05 | Eylea Hd | $14 |
| Abbvie | Meals · 2024-10-21 | Ozurdex | $19 |
| Abbvie | Meals · 2024-10-16 | Ozurdex | $13 |
| Alimera Sciences | Meals · 2024-08-21 | Yutiq | $14 |
| Alimera Sciences | Meals · 2024-05-30 | Yutiq | $15 |
| Astellas Pharma US | Meals · 2024-05-23 | Izervay | $14 |
| Alimera Sciences | Meals · 2024-02-20 | Yutiq | $23 |
| Alcon Research | Consulting · 2024-02-08 | None | $700 |
See earlier years (2023, 2022, 2021, 2019)
2023: $2,130
| Alcon Research | None | $2,100 | 3 payments
|
| Genentech USA | Vabysmo | $30 | 1 payment
|
2022: $6,948
| Alcon Research | None | $6,650 | 4 payments
|
| Apellis Pharmaceuticals | None | $128 | 1 payment
|
| Genentech USA | Vabysmo | $89 | 4 payments
|
| Regeneron Healthcare Solutions | Eylea | $80 | 4 payments
|
2021: $13,500
| Alcon Research | Constellation | $9,892 | 11 payments
|
| Alcon Vision | Constellation | $2,931 | 2 payments
|
| Regeneron Healthcare Solutions | Eylea | $212 | 6 payments
|
| Alimera Sciences | Iluvien | $176 | 4 payments
|
| Allergan | Ozurdex | $160 | 3 payments
|
| Genentech USA | Lucentis | $88 | 4 payments
|
| Novartis Pharmaceuticals | Beovu | $24 | 1 payment
|
| Summit Surgical | None | $18 | 1 payment
|
2019: $245
| Genentech USA | Lucentis | $224 | 2 payments
|
| Genentech | Non-Covered Product | $21 | 1 payment
|
Professional record
- NPI
- 1083855670
- Licence
- CA A121303, FL ME149236California A121303: Current · expires 2027-10-31Florida ME149236: Active
- Trained
- Stanford University School of Medicine, 2008
- Group
- Stanford Health Care · Vitreo-Retinal Medical Group, Inc. · Erie Retinal Surgery, Inc.
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207W00000X (207W00000X); Federal specialty code 207WX0107X (207WX0107X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2009-03-12
- NPI last updated
- 2025-04-07
- NPI record certified
- 2025-04-07
This is when the NPI record was last certified, not a medical board exam.